{"schema_version":"secwatch.filing_event.v1","accession":"0001815776-25-000036","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2025-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.841832+00:00","generated_at":"2026-05-19T15:58:31.658895+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"LENZ Therapeutics annual meeting elects directors, ratifies auditor","bullets":["17,983,676 of 27,544,520 shares represented at June 10, 2025 annual meeting.","Class III directors Kimberlee C. Drapkin and Zach Scheiner elected with ~12.4M and ~12.7M votes for.","Class I directors Frederic Guerard and James McCollum elected with ~15.4M and ~15.4M votes for.","Ernst & Young LLP ratified as independent auditor for FY2025 with 17,979,770 votes for.","No proposals or business items beyond standard director elections and auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001815776-25-000036","json":"https://secwatch.observer/filing/0001815776-25-000036.json","markdown":"https://secwatch.observer/filing/0001815776-25-000036.md","text":"https://secwatch.observer/filing/0001815776-25-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000036/0001815776-25-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000036/lenz-20250610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T15:58:31.658895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}